NEA Management Company as of Sept. 30, 2023
Portfolio Holdings for NEA Management Company
NEA Management Company holds 46 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Coursera (COUR) | 18.6 | $241M | 13M | 18.69 | |
| Arcellx Common Stock (ACLX) | 10.4 | $134M | 3.7M | 35.88 | |
| Savara (SVRA) | 7.1 | $93M | 25M | 3.78 | |
| Verona Pharma Sponsered Ads (VRNA) | 7.0 | $91M | 5.1M | 17.82 | |
| Crispr Therapeutics Namen Akt (CRSP) | 5.6 | $72M | 1.6M | 45.39 | |
| Mirum Pharmaceuticals (MIRM) | 5.3 | $69M | 2.2M | 31.60 | |
| Rhythm Pharmaceuticals (RYTM) | 5.2 | $67M | 2.9M | 22.93 | |
| Geron Corporation (GERN) | 3.7 | $48M | 23M | 2.12 | |
| Nextnav Common Stock (NN) | 3.3 | $42M | 8.2M | 5.14 | |
| Monte Rosa Therapeutics (GLUE) | 2.8 | $37M | 7.7M | 4.79 | |
| Reneo Pharmaceuticals (RPHM) | 2.8 | $36M | 4.8M | 7.62 | |
| CVRX (CVRX) | 2.8 | $36M | 2.4M | 15.17 | |
| Celcuity (CELC) | 2.5 | $32M | 1.3M | 25.43 | |
| Aurinia Pharmaceuticals (AUPH) | 2.4 | $31M | 4.0M | 7.77 | |
| Sagimet Biosciences Com Ser A (SGMT) | 2.1 | $27M | 3.9M | 7.04 | |
| Trevi Therapeutics (TRVI) | 1.9 | $25M | 11M | 2.18 | |
| Desktop Metal Com Cl A | 1.6 | $21M | 14M | 1.46 | |
| X4 Pharmaceuticals (XFOR) | 1.3 | $16M | 15M | 1.09 | |
| Bright Health Group Com New (NEUE) | 1.3 | $16M | 2.7M | 5.97 | |
| ZeroFox Holdings | 1.2 | $16M | 18M | 0.88 | |
| Allakos (ALLK) | 1.1 | $14M | 6.1M | 2.27 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 1.0 | $13M | 17M | 0.78 | |
| Gossamer Bio (GOSS) | 1.0 | $13M | 16M | 0.83 | |
| Black Diamond Therapeutics (BDTX) | 1.0 | $13M | 4.4M | 2.87 | |
| Phathom Pharmaceuticals (PHAT) | 0.9 | $12M | 1.3M | 9.59 | |
| Champions Oncology Com New (CSBR) | 0.8 | $11M | 1.7M | 6.21 | |
| Inozyme Pharma (INZY) | 0.8 | $10M | 2.4M | 4.20 | |
| Tuya Sponsered Ads (TUYA) | 0.6 | $7.6M | 4.9M | 1.55 | |
| Glycomimetics (GLYC) | 0.6 | $7.1M | 4.8M | 1.50 | |
| Inventiva Sa Ads (IVA) | 0.5 | $6.3M | 1.5M | 4.34 | |
| Buzzfeed Class A Com | 0.5 | $5.9M | 15M | 0.38 | |
| Minerva Surgical | 0.4 | $5.7M | 34M | 0.16 | |
| Nkarta (NKTX) | 0.4 | $5.0M | 3.6M | 1.39 | |
| Marker Therapeutics Com New (MRKR) | 0.4 | $4.9M | 1.1M | 4.54 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.3 | $4.1M | 430k | 9.56 | |
| Regulus Therapeutics | 0.2 | $2.7M | 1.9M | 1.37 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 0.2 | $2.6M | 2.4M | 1.09 | |
| Affimed Therapeutics B V | 0.2 | $2.1M | 4.4M | 0.48 | |
| Senti Biosciences Ord (SNTI) | 0.1 | $1.8M | 4.4M | 0.41 | |
| Ikena Oncology (IKNA) | 0.1 | $707k | 182k | 3.90 | |
| Synlogic Com New (SYBX) | 0.0 | $615k | 282k | 2.18 | |
| Surf Air Mobility (SRFM) | 0.0 | $610k | 440k | 1.39 | |
| Addex Therapeutics Sponsored Ads | 0.0 | $408k | 180k | 2.27 | |
| Wheels Up Experience Com Cl A (UP) | 0.0 | $220k | 106k | 2.07 | |
| Eargo Com New | 0.0 | $189k | 87k | 2.17 | |
| Akari Therapeutics Sponsored Adr (AKTX) | 0.0 | $89k | 23k | 3.95 |
